Counterfeit batches of Crestor brand lipid-lowering drugs contained ingredients from Chinese pharmaceutical producers, Minister of Health and Welfare Chen Shih-chung (陳時中) said yesterday after being subjected to a barrage of questions from a lawmaker.
A recall was issued on Tuesday for all of AstraZeneca’s Crestor tablets following a discovery last week that two batches of the drug prescribed to 570,000 National Health Insurance patients were counterfeits made from atorvastatin, a cheaper drug whose patent had expired.
The Ministry of Health and Welfare did not release any information regarding the quantity, distribution or origin of the fake drugs until yesterday, when Democratic Progressive Party Legislator Liu Chien-kuo (劉建國) grilled Chen on the issue during a legislative session.
Photo: CNA
Following Liu’s questions, Chen said that the fake drugs’ ingredients were mailed from China to Taiwan, but the identity of many individuals involved in their production and distribution remained unknown to authorities.
The ministry is considering sending investigators to China, Chen said, adding that judicial authorities have taken charge of the investigation.
Liu said that the majority of the imported products seized by the Food and Drug Administration at customs offices for being counterfeits or failing to meet safety standards originated in China.
Separately yesterday, Premier Lin Chuan (林全) pledged to comprehensively overhaul the nation’s drug safety standards during a meeting he chaired at the Executive Yuan.
“This incident is a test for our entire medical safety system and especially for the ministry’s agencies responsible for protecting the nation’s drug safety, as it will show whether their work has won the public’s trust,” Lin said. “We must use this opportunity to completely re-evaluate our performance.”
The primary suspect involved in counterfeiting the drug has been apprehended, Lin said, acknowledging the efforts of police, prosecutors and the ministry to hold the suspect accountable.
The government has requested the assistance of the pharmaceutical sector in recalling and replacing the affected products, he added.
The ministry must ensure the complete recovery and destruction of the fake drugs, and it must make information available to avoid an unnecessary panic, Lin said, adding that an inspection of all commonly prescribed and high-value pharmaceuticals would begin immediately.
Lin said the Cabinet would at the earliest opportunity review existing procedures, including those for dealing with fake drugs; tracking the production and distribution of medicines; quality control regulations; hospital inventory inspections; the mechanism for reporting fake drugs; and methods for their disposal.
The government must protect the public’s access to safe medicines that are essential for public health, uphold the nation’s reputation for effective regulation of medical products and restore public confidence in the government, he added.
The US Department of State yesterday criticized Beijing over its misrepresentation of the US’ “one China” policy in the latest diplomatic salvo between the two countries over a bid by Taiwan to regain its observer status at the World Health Assembly, the decisionmaking body of the WHO. “The PRC [People’s Republic of China] continues to publicly misrepresent U.S. policy,” Department of State spokesman Ned Price wrote on Twitter. “The United States does not subscribe to the PRC’s ‘one China principle’ — we remain committed to our longstanding, bipartisan one China policy, guided by the Taiwan Relations Act, Three Joint Communiques, and
FATES LINKED: The US president said that sanctions on Russia over Ukraine must exact a ‘long-term price,’ because otherwise ‘what signal does that send to China?’ US President Joe Biden yesterday vowed that US forces would defend Taiwan militarily in the event of a Chinese attack in his strongest statement to date on the issue. Beijing is already “flirting with danger,” Biden said following talks with Japanese Prime Minister Fumio Kishida in Tokyo, in which the pair agreed to monitor Chinese naval activity and joint Chinese-Russian exercises. Asked if Washington was willing to get involved militarily to defend Taiwan, he replied: “Yes.” “That’s the commitment we made,” Biden said. “We agreed with the ‘one China’ policy, we signed on to it ... but the idea that it can be
INFORMATION LEAKED: Documents from Xinjiang purportedly showed top leaders in Beijing calling for a forceful crackdown and even orders to shoot to kill Chinese President Xi Jinping (習近平) yesterday held a videoconference with UN High Commissioner for Human Rights Michelle Bachelet as she visited Xinjiang during a mission overshadowed by fresh allegations of Uighur abuses and fears she is being used as a public relations tool. The Chinese Communist Party (CCP) has been accused of detaining more than 1 million Uighurs and other Muslim minorities in the region as part of a years-long crackdown the US and lawmakers in other Western nations have labeled a “genocide.” China denies the allegations. Bachelet was expected to visit the cities of Urumqi and Kashgar on a six-day tour. The US
SUBTLE? While Biden said the US policy of ‘strategic ambiguity’ on Taiwan had not changed, the group targeted China and Russia without naming them Leaders of Australia, India, Japan and the US yesterday warned against attempts to “change the status quo by force,” as concerns grow about whether China could invade Taiwan. The issue of Taiwan loomed over a leadership meeting in Tokyo of the Quadrilateral Security Dialogue (Quad) nations — the US, Japan, Australia and India — who stressed their determination to ensure a free and open Indo-Pacific region in the face of an increasingly assertive China, although Japanese Prime Minister Fumio Kishida said the group was not targeting any one country. The four leaders said in a joint statement issued after their talks
RSS